These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 16832664)

  • 1. Increased syndecan-1 in serum is related to early nephropathy in type 1 diabetes mellitus patients.
    Svennevig K; Kolset SO; Bangstad HJ
    Diabetologia; 2006 Sep; 49(9):2214-6. PubMed ID: 16832664
    [No Abstract]   [Full Text] [Related]  

  • 2. High lipoprotein(a) levels in type 1 and type 2 diabetic patients with macroalbuminuria.
    Relimpio F; Acosta D; Losada F; Pumar A; Serrera JL; Mangas MA; Astorga R
    Diabetes Care; 1997 Dec; 20(12):1921-2. PubMed ID: 9405921
    [No Abstract]   [Full Text] [Related]  

  • 3. Plasma osteoprotegerin concentrations in type 1 diabetic patients with albuminuria.
    Elsamahy MH; Elhenawy YI; Nawar MM
    J Diabetes Complications; 2015; 29(4):563-7. PubMed ID: 25744546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between serum bilirubin concentrations and diabetic nephropathy in Shanghai Han's patients with type 1 diabetes mellitus.
    Li X; Zhang L; Chen H; Guo K; Yu H; Zhou J; Li M; Li Q; Li L; Yin J; Liu F; Bao Y; Han J; Jia W
    BMC Nephrol; 2017 Mar; 18(1):114. PubMed ID: 28363276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetic nephropathy: has the time come to move beyond plasma creatinine?
    Osman MM; Ahmed MH
    Ren Fail; 2006; 28(6):525-6. PubMed ID: 16928625
    [No Abstract]   [Full Text] [Related]  

  • 6. Increased plasma concentration of von Willebrand factor in insulin dependent diabetics with incipient nephropathy.
    Jensen T
    BMJ; 1989 Jan; 298(6665):27-8. PubMed ID: 2492846
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hyperlipidemia as a factor in the development and progress of diabetic nephropathy].
    Shestakova MV; Dedov II; Neverov NI; Severgina ES; Diuzhev TG; Ponomarev AB
    Probl Endokrinol (Mosk); 1993; 39(5):7-9. PubMed ID: 8108357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Albuminuria and VEGF as early markers of cardiovascular disturbances in young type 1 diabetic patients.
    Naskret D; Zozulinska-Ziolkiewicz DA; Dankowski R; Wysocki H; Wierusz-Wysocka B
    Microvasc Res; 2010 Dec; 80(3):440-4. PubMed ID: 20659485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microalbuminuria in insulin-dependent diabetes is associated with high levels of prothrombin fragment 1 + 2.
    Gruden G; Bazzan M; Stella S; Pagano G; Pileri A; Cavallo-Perin P
    Thromb Res; 1993 Dec; 72(6):541-6. PubMed ID: 8128458
    [No Abstract]   [Full Text] [Related]  

  • 10. Serum osteoprotegerin and tumor necrosis factor related apoptosis inducing-ligand (TRAIL) are elevated in type 2 diabetic patients with albuminuria and serum osteoprotegerin is independently associated with the severity of diabetic nephropathy.
    Chang YH; Lin KD; He SR; Hsieh MC; Hsiao JY; Shin SJ
    Metabolism; 2011 Aug; 60(8):1064-9. PubMed ID: 21251686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma homocysteine is related to albumin excretion rate in patients with diabetes mellitus: a new link between diabetic nephropathy and cardiovascular disease?
    Chico A; Pérez A; Córdoba A; Arcelús R; Carreras G; de Leiva A; González-Sastre F; Blanco-Vaca F
    Diabetologia; 1998 Jun; 41(6):684-93. PubMed ID: 9662051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum adiponectin and progression of diabetic nephropathy in patients with type 1 diabetes.
    Saraheimo M; Forsblom C; Thorn L; Wadén J; Rosengård-Bärlund M; Heikkilä O; Hietala K; Gordin D; Frystyk J; Flyvbjerg A; Groop PH;
    Diabetes Care; 2008 Jun; 31(6):1165-9. PubMed ID: 18346990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased plasma osteoprotegerin concentrations in Type 1 diabetes with albuminuria.
    Wang ST; Xu JM; Wang M; Chen FL; Ding G
    Clin Nephrol; 2013 Mar; 79(3):192-8. PubMed ID: 23073066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum concentrations of laminin P1 in diabetics with advanced nephropathy.
    Pietschmann P; Schernthaner G; Schnack CH; Gaube S
    J Clin Pathol; 1988 Sep; 41(9):929-32. PubMed ID: 3192751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. YKL-40, a marker of inflammation and endothelial dysfunction, is elevated in patients with type 1 diabetes and increases with levels of albuminuria.
    Rathcke CN; Persson F; Tarnow L; Rossing P; Vestergaard H
    Diabetes Care; 2009 Feb; 32(2):323-8. PubMed ID: 18957531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma homocysteine and microvascular complications in type 1 diabetes.
    Vaccaro O; Perna AF; Mancini FP; Iovine C; Cuomo V; Sacco M; Tufano A; Rivellese AA; Ingrosso D; Riccardi G
    Nutr Metab Cardiovasc Dis; 2000 Dec; 10(6):297-304. PubMed ID: 11302003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased levels of alpha-defensin (-1, -2 and -3) in type 1 diabetic patients with nephropathy.
    Saraheimo M; Forsblom C; Pettersson-Fernholm K; Flyvbjerg A; Groop PH; Frystyk J;
    Nephrol Dial Transplant; 2008 Mar; 23(3):914-8. PubMed ID: 18003664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of nephropathy in diabetes mellitus: problems of methodology and terminology.
    Jarrett RJ; Viberti GC
    Diabetologia; 1985 Mar; 28(3):181. PubMed ID: 3996796
    [No Abstract]   [Full Text] [Related]  

  • 19. [The role of Na/Li countertransport in the pathogenesis of diabetic nephropathy].
    Mozgovaia ME; Shestakova MV
    Ter Arkh; 1994; 66(10):25-6. PubMed ID: 7863439
    [No Abstract]   [Full Text] [Related]  

  • 20. Elevated matrix metalloproteinase-2 and -9 in urine, but not in serum, are markers of type 1 diabetic nephropathy.
    Diamant M; Hanemaaijer R; Verheijen JH; Smit JW; Radder JK; Lemkes HH
    Diabet Med; 2001 May; 18(5):423-4. PubMed ID: 11472458
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.